Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with relapsed or refractory AML for which no standard therapies are anticipated to result in durable remission
Newly diagnosed Acute Myeloid Leukemia who are not considered suitable for other treatments.
You may not be if
Administration of anticancer agents (other than hydroxyurea) within 2 weeks prior to first dose of study drug, and administration of hydroxyurea within 24 hours prior to first dose of study drug
Participation in any other trial with an investigational product within the previous 30 days.
Uncontrolled intercurrent illness including, but not limited to, active infection, symptomatic congestive heart failure, cardiac arrhythmia or psychiatric illness/social situations